The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

H Jiang, J Fan, L Cheng, P Hu, R Liu - OncoTargets and therapy, 2018 - Taylor & Francis
Background Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …
被引用次数：48 相关文章

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

H Jiang, J Fan, L Cheng, P Hu, R Liu - OncoTargets and Therapy, 2018 - dovepress.com
Background: Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells.

H Jiang, J Fan, L Cheng, P Hu, R Liu - Oncotargets and Therapy, 2018 - europepmc.org
Background Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

H Jiang, J Fan, L Cheng, P Hu… - OncoTargets and …, 2018 - search.proquest.com
Background: Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …

[引用][C] The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

H Jiang, J Fan, L Cheng, P Hu, R Liu - OncoTargets and Therapy, 2018 - cir.nii.ac.jp
The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast
cancer cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF] semanticscholar.org

[PDF][PDF] The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

J Fan - OncoTargets and Therapy, 2018 - pdfs.semanticscholar.org
Background: Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells.

H Jiang, J Fan, L Cheng, P Hu… - OncoTargets & …, 2018 - search.ebscohost.com
Background: Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …
[PDF] scienceopen.com

[PDF][PDF] The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

J Fan - OncoTargets and Therapy, 2018 - scienceopen.com
Background: Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …
[HTML] nih.gov

[HTML][HTML] The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

H Jiang, J Fan, L Cheng, P Hu, R Liu - OncoTargets and therapy, 2018 - ncbi.nlm.nih.gov
Background Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

H Jiang, J Fan, L Cheng, P Hu… - OncoTargets and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Most breast cancers are estrogen dependent and were sensitive to endocrine
therapy, and genistein (GEN) shows strong affinity with human oestrogen receptor beta …